$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
The second generation targeted therapy drug for lung cancer-Dacomitinib
2025-10-19 11:44:20
Check Details
Does paclitaxel for injection need to be stored away from light?
2025-10-19 11:44:20
Check Details
Safety and effectiveness of Zangda in the treatment of ALK-positive metastatic non-small cell lung cancer
2025-10-19 11:44:20
Check Details
How should patients with lung cancer use Zangada correctly?
2025-10-19 11:44:20
Check Details
Analysis of the efficacy and adverse reactions of XL184 in the treatment of non-small cell lung cancer
2025-10-19 11:44:20
Check Details
None
2025-10-19 11:44:20
Check Details
Gitarel can treat non-small cell lung cancer with EGFR gene mutations and lung squamous cell carcinoma with disease progression after chemotherapy
2025-10-19 11:44:20
Check Details
Gitari has good efficacy in treating lung squamous cell carcinoma
2025-10-19 11:44:20
Check Details
Effect data of XL184 in patients with RET-rearranged lung cancer
2025-10-19 11:44:20
Check Details
Gyterin is the first targeted drug that can significantly improve the overall survival of patients with common EGFR mutations compared with chemotherapy_ Kanghule
2025-10-19 11:44:20
Check Details
The role of broad-spectrum anticancer drug XL184 in RET-rearranged lung cancer
2025-10-19 11:44:20
Check Details
Giterinib (afatinib) can significantly extend the progression-free survival of patients with brain metastases compared with chemotherapy_ Kanghule
2025-10-19 11:44:20
Check Details
1
2
...
3875
3876
3877
3878
3879
3880
3881
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
2
Cemiplimab (Libtayo) Drug Information
3
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
4
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
5
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
6
A Revolutionary Targeted Therapy for Hematological Malignancies
7
A New Option for Advanced Renal Cell Carcinoma Treatment
8
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
9
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
10
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
11
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
12
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment